WOMBAT (ANZUP 2201): A Phase 2, Single-arm Study of Bipolar Androgen Therapy in Patients with Nonmetastatic Castration-resistant Prostate Cancer with Prostate-specific Antigen Progression on Darolutamide

Barak Talmor, Carole A. Harris, Christopher Gianacas, David Pook, Thean Hsiang Tan, Ian D. Davis, Laurence Krieger, Gavin Marx, Arsha Anton, Sharad Sharma, Jeffrey C. Goh, Kay Xu, Ganes Pranavan, Haryana M. Dhillon, Emmanuel S. Antonarakis, Samuel R. Denmeade, Lisa Horvath, Samantha R. Oakes, Ray Allen, Antoinette Fontela, Elizabeth Reich, Megan Crumbaker, Joshua Hurwitz, Anthony M. Joshua

Open source

DOI
10.1016/j.euo.2026.02.004
Published
2026-04
Container
European Urology Oncology
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.euo.2026.02.004,
  title = {WOMBAT (ANZUP 2201): A Phase 2, Single-arm Study of Bipolar Androgen Therapy in Patients with Nonmetastatic Castration-resistant Prostate Cancer with Prostate-specific Antigen Progression on Darolutamide},
  author = {Barak Talmor and Carole A. Harris and Christopher Gianacas and David Pook and Thean Hsiang Tan and Ian D. Davis and Laurence Krieger and Gavin Marx and Arsha Anton and Sharad Sharma and Jeffrey C. Goh and Kay Xu and Ganes Pranavan and Haryana M. Dhillon and Emmanuel S. Antonarakis and Samuel R. Denmeade and Lisa Horvath and Samantha R. Oakes and Ray Allen and Antoinette Fontela and Elizabeth Reich and Megan Crumbaker and Joshua Hurwitz and Anthony M. Joshua},
  year = {2026},
  journal = {European Urology Oncology},
  doi = {10.1016/j.euo.2026.02.004},
  url = {https://doi.org/10.1016/j.euo.2026.02.004}
}

RIS

TY  - JOUR
TI  - WOMBAT (ANZUP 2201): A Phase 2, Single-arm Study of Bipolar Androgen Therapy in Patients with Nonmetastatic Castration-resistant Prostate Cancer with Prostate-specific Antigen Progression on Darolutamide
AU  - Barak Talmor
AU  - Carole A. Harris
AU  - Christopher Gianacas
AU  - David Pook
AU  - Thean Hsiang Tan
AU  - Ian D. Davis
AU  - Laurence Krieger
AU  - Gavin Marx
AU  - Arsha Anton
AU  - Sharad Sharma
AU  - Jeffrey C. Goh
AU  - Kay Xu
AU  - Ganes Pranavan
AU  - Haryana M. Dhillon
AU  - Emmanuel S. Antonarakis
AU  - Samuel R. Denmeade
AU  - Lisa Horvath
AU  - Samantha R. Oakes
AU  - Ray Allen
AU  - Antoinette Fontela
AU  - Elizabeth Reich
AU  - Megan Crumbaker
AU  - Joshua Hurwitz
AU  - Anthony M. Joshua
PY  - 2026
JO  - European Urology Oncology
DO  - 10.1016/j.euo.2026.02.004
UR  - https://doi.org/10.1016/j.euo.2026.02.004
ER  - 

APA

Talmor, B., Harris, C. A., Gianacas, C., Pook, D., Tan, T. H., Davis, I. D., Krieger, L., Marx, G., Anton, A., Sharma, S., Goh, J. C., Xu, K., Pranavan, G., Dhillon, H. M., Antonarakis, E. S., Denmeade, S. R., Horvath, L., Oakes, S. R., Allen, R., Fontela, A., Reich, E., Crumbaker, M., Hurwitz, J., & Joshua, A. M. (2026). WOMBAT (ANZUP 2201): A Phase 2, Single-arm Study of Bipolar Androgen Therapy in Patients with Nonmetastatic Castration-resistant Prostate Cancer with Prostate-specific Antigen Progression on Darolutamide. European Urology Oncology. https://doi.org/10.1016/j.euo.2026.02.004

Source records